Roivant Sciences Ltd. Contracts & Agreements

52 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement, dated as of May 29, 2012, by and between Glaxo Group Limited and Welichem Biotech Inc
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
First Amendment to Credit Agreement by and among Dermavant Sciences Ltd., Dermavant Holdings Limited, Dermavant Sciences IRL Limited, Dermavant Sciences GmbH, certain subsidiaries...
Credit Agreements
Roivant Sciences Ltd.
2024
Second Amendment to Funding Agreement, dated as of July 10, 2018, by and between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P., dated as of May 24, 2024
Funding Agreements
Roivant Sciences Ltd.
2024
First Amendment to Revenue Interest Purchase and Sale Agreement by and among Dermavant Sciences GmbH, certain purchasers and U.S. Bank National Association as collateral agent,...
Purchase Agreements
Roivant Sciences Ltd.
2024
Employment Agreement between Roivant Sciences, Inc. and Richard Pulik, dated as of August 31, 2021
Employment Agreements
Roivant Sciences Ltd.
2024
Employment Agreement between Roivant Sciences, Inc. and Rakhi Kumar, dated as of June 5, 2023
Employment Agreements
Roivant Sciences Ltd.
2024
Stock Purchase Agreement, by and among Roche Holdings, Inc., Roivant Sciences Ltd., Pfizer Inc. and Telavant Holdings, Inc., dated as of October 22, 2023
Stock Agreements
Roivant Sciences Ltd.
2023
Form of Common Share Purchase and Sale Agreement
Share Agreements
Roivant Sciences Ltd.
2023
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Roivant Sciences Ltd.
2023
Amended & Restated Roivant Sciences Ltd. Employee Stock Purchase Plan
Stock Agreements
Roivant Sciences Ltd.
2023
Form of Stock Option Grant Notice under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan
Bonus & Incentive Agreements
Roivant Sciences Ltd.
2023
Form of Restricted Stock Unit Award Grant Notice under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan
Bonus & Incentive Agreements
Roivant Sciences Ltd.
2023
Form of Performance Option Grant Notice under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan
Bonus & Incentive Agreements
Roivant Sciences Ltd.
2023
Form of Capped Value Appreciation Right Award Grant Notice under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan
Bonus & Incentive Agreements
Roivant Sciences Ltd.
2023
Form of Stock Option Grant Notice under the Roivant Sciences Ltd. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Roivant Sciences Ltd.
2023
Form of Restricted Stock Unit Award Grant Notice under the Roivant Sciences Ltd. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Roivant Sciences Ltd.
2023
Separation and Mutual Release Agreement
Separation Agreements
Roivant Sciences Ltd.
2023
License and Collaboration Agreement dated as of November 21, 2022
Collaboration Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Investor Rights Agreement dated as of November 21, 2022
Investor Rights Agreements
Roivant Sciences Ltd.
2023
Underwriting Agreement, dated as of February 2, 2023, by and among Roivant Sciences Ltd., Goldman Sachs & Co. LLC, SVB Securities LLC, Cowen and Company, LLC and Cantor Fitzgerald...
Underwriting Agreements
Roivant Sciences Ltd.
2023
Partial Termination and Supplementary Fee Agreement relating to the Clinical Supply Agreement and Commercial Supply Agreement, dated as of July 25, 2022, by and between...
Termination Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Master Commercial Manufacturing Supply Agreement, dated as of July 1, 2022, by and between Dermavant Sciences GmbH and Thermo Fisher Scientific Cork Limited
Supply Agreements
Roivant Sciences Ltd.
2022
Underwriting Agreement, dated as of November 8, 2022, by and among Roivant Sciences Ltd., Cantor Fitzgerald & Co., and the Selling Shareholders named therein
Underwriting Agreements
Roivant Sciences Ltd.
2022
Form of Transaction Support Agreement, dated as of May 1, 2021, by and among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp. and certain shareholders of Roivant...
Shareholders Agreements
Roivant Sciences Ltd.
2022
Amendment No. 1 to the Support Agreement, dated as of June 9, 2021, by and among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., Patient Square Capital LLC and certain...
Shareholders Agreements
Roivant Sciences Ltd.
2022
Investor Rights Agreement, dated as of September 13, 2021, by and among Priovant Holdings, Inc., Roivant Sciences Ltd. and Pfizer Inc
Investor Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
License and Collaboration Agreement, dated as of September 13, 2021, by and between Pfizer Inc. and Priovant, Inc
Collaboration Agreements
Roivant Sciences Ltd.
2022
Amendment No. 1 to License and Collaboration Agreement, dated as of June 10, 2022, by and between Pfizer Inc. and Priovant, Inc
Collaboration Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Business Combination Agreement, dated as of May 1, 2021, by and among Montes Archimedes Acquisition Corp., Roivant Sciences Ltd. and Rhine Merger Sub, Inc
Merger Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Amendment No. 1 to the Business Combination Agreement, dated June 9, 2021, by and among Montes Archimedes Acquisition Corp., Roivant Sciences Ltd. and Rhine Merger Sub, Inc
Merger Agreements
Roivant Sciences Ltd.
2022
Third Amended and Restated Registration Rights Agreement, dated as of May 1, 2021, by and among Roivant Sciences Ltd. and the parties thereto
Registration Rights Agreements
Roivant Sciences Ltd.
2022
Form of Subscription Agreement
Subscription Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Sponsor Support Agreement, dated as of May 1, 2021, by and among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., Patient Square Capital LLC and certain shareholders of...
Shareholders Agreements
Roivant Sciences Ltd.
2022
Exclusive License Agreement by and between Eisai Co. Ltd. and Pharmavant 7 GmbH, dated as of November 24, 2021
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2022
Common Shares Purchase Agreement, dated February 14, 2022, between Roivant Sciences Ltd. and CF Principal Investments LLC
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Third Amendment to Cross License Agreement, dated December 9, 2021, by and between Genevant Sciences GmbH and Arbutus Biopharma Corporation
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Bonus Award Letter from Roivant Sciences Inc. to Benjamin Zimmer, dated as of December 21, 2021
Bonus & Incentive Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Agreement and General Release Between Roivant Sciences Ltd., Roivant Sciences, Inc. and Benjamin Zimmer
Release Agreements
Roivant Sciences Ltd.
2021
Amendment No. 2 to the Sponsor Support Agreement, dated as of September 30, 2021, among Roivant, MAAC, MAAC Sponsor and the other parties thereto
Roivant Sciences Ltd.
2021
Asset Purchase Agreement, dated as of July 10, 2018, by and among GlaxoSmithKline Intellectual Property Development Ltd., Glaxo Group Limited and Dermavant Sciences GmBH
Purchase Agreements
Roivant Sciences Ltd.
2021
First Amendment to the Asset Purchase Agreement, dated as of August 31, 2012, by and between Glaxo Group Limited and Welichem Biotech, Inc
Purchase Agreements
Roivant Sciences Ltd.
2021
Collaboration and License Agreement, dated as of January 15, 2020, by and between Dermavant Sciences GmbH and Japan Tobacco Inc
Collaboration Agreements
Roivant Sciences Ltd.
2021
Clinical Supply and Manufacturing Agreement, dated August 20, 2018, by and between Dermavant Sciences GmbH and GlaxoSmithKline
Supply Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Commercial Supply and Manufacturing Agreement, dated April 1, 2019, by and between Dermavant Sciences GmbH and GlaxoSmithKline
Supply Agreements
Roivant Sciences Ltd.
2021
Funding Agreement, dated as of July 10, 2018, by and between Demavant Sciences GmBH and NovaQuest Co-Investment Fund VIII, L.P
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
First Amendment to Funding Agreement dated as of October 11, 2018, by and between Dermavant Sciences GmBH and NovaQuest Co-Investment Fund VIII, L.P
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2021
Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan
Bonus & Incentive Agreements
Roivant Sciences Ltd.
2021
Form of Roivant Sciences Ltd. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Amended and Restated Employment Agreement between Roivant Sciences, Inc. and Vivek Ramaswamy, dated as of May 14, 2021
Employment Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Executive Employment Agreement between Roivant Sciences, Inc. and Matthew Gline, dated as of May 14, 2021
Employment Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Executive Employment Agreement between Roivant Sciences, Inc. and Eric Venker, dated as of May 14, 2021
Employment Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Executive Employment Agreement between Roivant Sciences, Inc. and Benjamin Zimmer, dated as of May 14, 2021
Employment Agreements
Roivant Sciences Ltd.
2021